| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5705099 | Ophthalmology | 2017 | 7 Pages |
Abstract
The risk for graft rejection after DMEK is low, and an even smaller minority requires a regraft. After intensified local corticosteroid therapy, most patients show stable visual acuity and CCT, although ECD decreases. The occurrence of immune reactions up to 2 years after surgery predominantly in patients not receiving corticosteroids supports the prolonged use of corticosteroids after DMEK.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Deniz MD, PhD, Onur Tuac, Friederike MD, Tisha P. MD, Silvia MD, Martin PhD, Björn O. MD, Claus MD,